Similar articles for PMID: 12496670

Year	Number of Results
1950	1
1982	1
1985	1
1986	1
1988	1
1989	2
1991	6
1993	5
1994	2
1995	4
1996	8
1997	11
1998	5
1999	9
2000	7
2001	14
2002	19
2003	17
2004	16
2005	12
2006	10
2007	4
2008	7
2009	5
2010	4
2011	3
2012	4
2013	2
2014	5
2015	5
2016	3
2017	2
2018	4
2019	1
2020	1
2021	2
2022	3
2024	0

1

Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans.

Kaperonis N, Bakris G. Kaperonis N, et al. Curr Opin Nephrol Hypertens. 2003 Jan;12(1):79-84. doi: 10.1097/00041552-200301000-00013. Curr Opin Nephrol Hypertens. 2003. PMID: 12496670 Review.

2

Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes.

Flack JM, Hamaty M. Flack JM, et al. J Hypertens Suppl. 1999 Feb;17(1):S19-24. J Hypertens Suppl. 1999. PMID: 10340840 Review.

3

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group. Wright JT Jr, et al. JAMA. 2002 Nov 20;288(19):2421-31. doi: 10.1001/jama.288.19.2421. JAMA. 2002. PMID: 12435255 Clinical Trial.

4

[Are all antihypertensive drugs renoprotective?].

Wolf S, Risler T. Wolf S, et al. Herz. 2004 May;29(3):248-54. doi: 10.1007/s00059-003-2508-6. Herz. 2004. PMID: 15167950 Review. German.

5

Renal protection and antihypertensive drugs: current status.

Salvetti A, Mattei P, Sudano I. Salvetti A, et al. Drugs. 1999 May;57(5):665-93. doi: 10.2165/00003495-199957050-00002. Drugs. 1999. PMID: 10353294 Review.

6

Treatment of hypertension in chronic kidney disease.

Toto RD. Toto RD. Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016. Semin Nephrol. 2005. PMID: 16298269 Review.

7

Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.

Jamerson KA. Jamerson KA. Am J Kidney Dis. 2000 Sep;36(3 Suppl 1):S24-30. doi: 10.1053/ajkd.2000.9688. Am J Kidney Dis. 2000. PMID: 10986156 Review.

8

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Bakris GL, et al. Am J Kidney Dis. 2000 Sep;36(3):646-61. doi: 10.1053/ajkd.2000.16225. Am J Kidney Dis. 2000. PMID: 10977801 Review.

9

Diabetic renal disease in African Americans.

Crook ED. Crook ED. Am J Med Sci. 2002 Feb;323(2):78-84. doi: 10.1097/00000441-200202000-00004. Am J Med Sci. 2002. PMID: 11863083 Review.

10

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R. Chaturvedi S, et al. Cochrane Database Syst Rev. 2014 Feb 1;(2):CD008117. doi: 10.1002/14651858.CD008117.pub2. Cochrane Database Syst Rev. 2014. PMID: 24488616 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

206 results

Results by year